Nektar Therapeutics
(NKTR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -89,165 | -36,802 | -276,056 | -233,977 | -188,140 |
| Depreciation Amortization | -2,581 | -1,456 | 84,316 | 70,527 | 72,819 |
| Income taxes - deferred | N/A | N/A | N/A | -1,854 | -1,839 |
| Accounts receivable | 9 | -2,412 | 4,776 | 3,777 | 4,646 |
| Accounts payable and accrued liabilities | -3,266 | -988 | -2,884 | -9,328 | -9,997 |
| Other Working Capital | 4,201 | -6,659 | -19,940 | -15,068 | -11,834 |
| Other Operating Activity | 5,212 | 429 | 17,182 | 40,364 | 30,907 |
| Operating Cash Flow | $-85,590 | $-47,888 | $-192,606 | $-145,559 | $-103,438 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -343 | -157 | 380 | 617 | -595 |
| Purchase Of Investment | -173,504 | -105,059 | -511,699 | -372,821 | -249,724 |
| Sale Of Investment | 210,087 | 124,474 | 650,883 | 494,385 | 316,088 |
| Investing Cash Flow | $36,240 | $19,258 | $139,564 | $122,181 | $65,769 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 30,022 | 30,003 | 30 | 18 | 18 |
| Common Stock Repurchased | -3,000 | -3,000 | N/A | N/A | N/A |
| Other Financing Activity | 15,000 | 15,000 | 0 | 0 | 0 |
| Financing Cash Flow | $42,022 | $42,003 | $30 | $18 | $18 |
| Exchange Rate Effect | -9 | -8 | 62 | 54 | 152 |
| Beginning Cash Position | 35,277 | 35,277 | 88,227 | 88,227 | 88,227 |
| End Cash Position | 27,940 | 48,642 | 35,277 | 64,921 | 50,728 |
| Net Cash Flow | $-7,337 | $13,365 | $-52,950 | $-23,306 | $-37,499 |
| Free Cash Flow | |||||
| Operating Cash Flow | -85,590 | -47,888 | -192,606 | -145,559 | -103,438 |
| Capital Expenditure | -343 | -157 | -865 | -628 | -595 |
| Free Cash Flow | -85,933 | -48,045 | -193,471 | -146,187 | -104,033 |